All Articles

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.

Allegiant and Dollywood partner on a unique themed flight, tapping into the 'experience economy' and the powerful brand of a country music legend.

Fresh off its IPO, Lumexa Imaging's leadership heads to key conferences. Here’s what’s at stake as they pitch their growth strategy to investors.

A new FDA approval allows a lung cancer therapy to be given just once a month, a major shift promising to reduce clinic time and improve quality of life.

Lufax names Xiang Ji as its new CEO amid major financial struggles. The move signals a tighter grip from controlling shareholder Ping An Group.

A new program in Michigan uses AI to analyze existing CT scans, detecting silent heart risks and connecting patients to care before symptoms even appear.

Vexcel announces its 2026 plan to capture 5.2M km² of U.S. aerial imagery, powering critical industries from insurance to AI with unprecedented detail.

A new five-year deal will leverage patient-derived stem cells and AI to revolutionize the hunt for Alzheimer's cures, aiming to bridge a critical gap.

A new partnership aims to manufacture a life-saving gene therapy for NKH, a devastating rare disorder, driven by a family's relentless advocacy.

As it celebrates 50 years, SpringGreen is leveraging advanced AI partnerships to redefine lawn care, empowering franchisees and enhancing service.

New research reveals a swift move to AI in accounting, but professionals insist on one condition: technology will assist, not replace, human oversight.

With its burn treatment gaining traction and a pivotal wound care drug in late-stage trials, MediWound prepares to make its case to Wall Street.

Boundless Futures Foundation and Ladies Who Launch partner to provide funding and vital resources, creating a new ecosystem for mission-driven female founders.

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.

With a new regulatory chief, Ray Therapeutics accelerates its mission to bring its goggle-free optogenetic therapies for blindness through clinical trials.

A new network of local recycling facilities aims to solve the e-waste gap for small businesses, boosting data security and domestic materials recovery.

TMD Energy's new director, a capital markets expert, sparks a 6.6% stock gain and speculation of M&A or major fundraising on the horizon.

Profitable and with little debt, this holding company is leveraging a diverse portfolio as it prepares for a major stock market uplist. Here's a closer look.

Prestigious toxicology awards recognize UL Research Institutes' vital work on vaping health risks and innovative methods for assessing chemical safety.

Glean's new AI assistant promises to move beyond search to autonomous action, tackling enterprise AI adoption challenges with deep contextual understanding.